TBPH stock pitch - 2024-07-09

Added to YB: 2024-07-09

Pitch date: 2024-07-09

Theravance Biopharma, Inc.

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States.

Market Cap

$989.6M

Pitch Price

$8.97

Price Target

N/A

Dividend

N/A

EV/EBITDA

-22.51

P/E

33.66

EV/Sales

8.73

Sector

Pharmaceuticals

A summary for this pitch has not been created yet.